Request a Quote |

Cyprotex Highlights - August 2021


Our growing Physicochemical Screening group is moving to a dedicated facility within Alderley Park in the UK. We expect the state-of the art laboratory and office space to be operational in Q4 2021. Further expansion at Alderley Park is planned for 2022 and beyond!

Find out more

Watch our latest webinar to find out about exciting new developments in the field of toxicology prediction and how transcriptomics can be used to predict drug-induced liver injury (DILI).

Presented by our in-house expert, Paul Walker PhD, the webinar covers our ground-breaking research building the largest transcriptomic database in the world and how this platform can be used to predict DILI risk with greatly enhanced accuracy compared with existing HCS-based DILI models.

Watch the webinar

Cyprotex is co-presenting with Unilever at the 11th World Congress on Alternatives and Animal Use in the Life Sciences 2021.

The Unilever-sponsored session, titled: "Assessing non-specific cellular stress responses for Chemical Safety Assessment" is presented by Cyprotex's Head of Toxicology, Paul Walker PhD, and Unilever's Science Leader, Paul Russell PhD.

The session highlights the benefits of working in partnership to develop new non-animal approaches and showcases the collaboration between Unilever and Cyprotex.

Find out more

Announcing our latest service: Cardiotox Screen for cardiac safety liability assessment.

Using a high content multi-time point approach alongside analysis of calcium transients, the Cardiotox Screen panel assesses both structural and functional cardiotoxicity endpoints from a single cell population, and is able to accurately predict cardiotoxicity liabilities early in preclinical screening.

Find out more

Enquire about Cardiotox Screen

  • Evotec spin-off Topas Therapeutics announces further investment
  • Just - Evotec Biologics opens innovative cGMP manufacturing facility (J.POD® 1 US) in Redmond, Washington
  • Evotec SE reports first half-year results for 2021 and gives corporate updates

Read the press releases

  • Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:

Read the blog

Contact us

News categories


Contact us to discuss your ADME Tox issues or request a quote

North America (East Coast): +1-888-297-7683
Europe: +44 (0)1625 5051000


or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

By clicking on ‘Send’ I agree that my data is being transferred and used by Cyprotex and the affiliated Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our privacy policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below: